Moderna's mission is to deliver the greatest possible impact to people through mRNA medicines.

Join Moderna as we pursue the uncharted reaches of possibility and make your mark on the future of medicine.

Moderna initiates first-in-human dosing for mRNA-1653, a combination vaccine with the potential to protect against more than one disease – human metapneumovirus (hMPV virus) and parainfluenza virus.

Track the development of Moderna’s mRNA medicines. From preclinical development to commercial phase.

Find contact information, important phone numbers and addresses to Moderna head.

We are committed to creating an inclusive and diverse environment for our team members across the globe. Moderna employees drive our achievements in bringing innovative medicines to patients.

Read and download all Moderna-related news related to Moderna's COVID-19 vaccine, boosters, internal updates, and more from the year 2012 through 2022

Moderna’s goal is to deliver on the promise of mRNA science to create a new generation of transformative medicines for patients.

Overview of Moderna news, events & presentations, latest quarterly results, and Moderna's pipeline development programs.

Apr 24, 2024 · Moderna's mRNA platform has enabled the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases.